| 產(chǎn)品名稱(chēng) |
Aureobacterium sp. |
| 商品貨號(hào) |
B192031 |
| Application |
Opportunistic pathogen research |
| Isolation |
Blood and skin lesions of 39-year-old man with myelogenous leukemia |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
freeze-dried |
| Preceptrol® |
no |
| Type Strain |
no |
| Antibiotic Resistance |
Resistant to vancomycin |
| Comments |
Opportunistic pathogen |
| Medium |
ATCC® Medium 44: Brain Heart Infusion Agar/Broth
|
| Growth Conditions |
Temperature: 37.0°C Atmosphere: Aerobic |
| Name of Depositor |
FS Nolte |
| Special Collection |
NCRR Contract |
| References |
Nolte FS, et al. Vancomycin-resistant Aureobacterium species cellulitis and bacteremia in a patient with acute myelogenous leukemia. J. Clin. Microbiol. 34: 1992-1994, 1996. PubMed: 8818896
|
